Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Gralla

Showing results (101-110 of 326) with videos related to

Pageof 33
Sort By:
Pharmaceutisch Weekblad. Scientific Edition|October 18, 1991
Controlling cancer chemotherapy-induced emesis. An updateC Seynaeve, P H De Mulder, J Verweij, et al.
British Medical Journal (Clinical Research Ed.)|July 30, 1983
Antiemetics and cytotoxic drugsM G Kris, R J Gralla, L B Tyson, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Methodology in anti-emetic trialsR J Gralla, R A Clark, M G Kris, et al.
Toxicology|August 1, 1979
The dosing schedule dependent toxicities of adriamycin in beagle dogs and rhesus monkeysE J Gralla, R W Fleischman, Y K Luthra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1988
Dose-ranging evaluation of the serotonin antagonist GR-C507/75 (GR38032F) when used as an antiemetic in patients receiving anticancer chemotherapyM G Kris, R J Gralla, R A Clark, et al.
Cancer Treatment Reports|August 1, 1979
Phase II evaluation of vindesine in patients with non-small cell carcinoma of the lungR J Gralla, B G Raphael, R B Golbey, et al.
Cancer Treatment Reports|October 1, 1980
Phase II. Evaluation of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (AMSA) in patients with advanced sarcomaP P Sordillo, G B Magill, R J Gralla, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Quality of life assessment in individuals with lung cancer: testing the Lung Cancer Symptom Scale (LCSS)P J Hollen, R J Gralla, M G Kris, et al.
Cancer|August 15, 1992
Oral ondansetron for the control of delayed emesis after cisplatin. Report of a phase II study and a review of completed trials to manage delayed emesisM G Kris, L B Tyson, R A Clark, et al.
American Journal of Clinical Oncology|June 1, 1995
Syndrome of acute dyspnea related to combined mitomycin plus vinca alkaloid chemotherapyM P Rivera, M G Kris, R J Gralla, et al.
Pageof 33

Showing results (101-110 of 326) with videos related to

Sort By:
Pageof 33
Pharmaceutisch Weekblad. Scientific Edition|October 18, 1991
Controlling cancer chemotherapy-induced emesis. An updateC Seynaeve, P H De Mulder, J Verweij, et al.
British Medical Journal (Clinical Research Ed.)|July 30, 1983
Antiemetics and cytotoxic drugsM G Kris, R J Gralla, L B Tyson, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Methodology in anti-emetic trialsR J Gralla, R A Clark, M G Kris, et al.
Toxicology|August 1, 1979
The dosing schedule dependent toxicities of adriamycin in beagle dogs and rhesus monkeysE J Gralla, R W Fleischman, Y K Luthra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1988
Dose-ranging evaluation of the serotonin antagonist GR-C507/75 (GR38032F) when used as an antiemetic in patients receiving anticancer chemotherapyM G Kris, R J Gralla, R A Clark, et al.
Cancer Treatment Reports|August 1, 1979
Phase II evaluation of vindesine in patients with non-small cell carcinoma of the lungR J Gralla, B G Raphael, R B Golbey, et al.
Cancer Treatment Reports|October 1, 1980
Phase II. Evaluation of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (AMSA) in patients with advanced sarcomaP P Sordillo, G B Magill, R J Gralla, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Quality of life assessment in individuals with lung cancer: testing the Lung Cancer Symptom Scale (LCSS)P J Hollen, R J Gralla, M G Kris, et al.
Cancer|August 15, 1992
Oral ondansetron for the control of delayed emesis after cisplatin. Report of a phase II study and a review of completed trials to manage delayed emesisM G Kris, L B Tyson, R A Clark, et al.
American Journal of Clinical Oncology|June 1, 1995
Syndrome of acute dyspnea related to combined mitomycin plus vinca alkaloid chemotherapyM P Rivera, M G Kris, R J Gralla, et al.
Pageof 33